Sharps Technology INC 10-Q quarterly reports

SkyAI, Inc. (SKYA) reported its Q2 2026 results, highlighting substantial unrealized and realized losses on digital commodities, significant operating expenses, and a strategic pivot towards an agentic finance platform.

Sharps Technology, Inc. has adopted a limited duration stockholder rights plan to protect shareholder interests.

Sharps Technology, Inc. announced a major strategic shift to a digital asset treasury focused on Solana, raising $411 million, while reporting a significant net loss for Q3 2025 and spinning off its medical device manufacturing.

Sharps Technology, Inc. reported its first revenue in Q2 2025, bolstered by a significant capital raise, but continues to face operational losses and going concern doubts.

Sharps Technology reports a net income of $1.9 million for the quarter ended March 31, 2025, driven by a fair market value adjustment on warrants and the closing of a $20 million equity offering.

Sharps Technology reported no revenue for the third quarter of 2024, alongside a net loss, while navigating ongoing legal issues and strategic shifts.

Sharps Technology reported its Q2 2024 results, showing a net loss and ongoing challenges with commercialization, while also highlighting strategic partnerships and a potential asset acquisition.

Sharps Technology reported a net loss of $982,386 for the first quarter of 2024, as the company continues to focus on commercializing its safety syringe products.